Article
The TREM2 targeting small molecule Sob-AM2 improves cognition independent of Aβ plaque alteration in 5xFAD mice
2026-08-05
Abstract excerpt
<h4>Background</h4> Inflammation is an early event that substantially influences Alzheimer’s disease (AD) pathogenesis, making it a compelling target for therapeutic intervention. Sob-AM2 is a brain-penetrating thyromimetic drug capable of inducing the expression of microglial cell surface receptor TREM2, which mediates the switch from pro-inflammatory to a more restorative microglial state. <h4>Objective</h4> E...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9fa4d6bc-f134-5641-b8bf-1e9d1d1511d8
- DOI
- 10.64898/2026.07.31.741838
